Alerus Investment Advisors’s Pediatrix Medical MD Stock Holding History

Alerus Investment Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1K	Buy	+23	New	+$1.53K	﹤0.01%	249

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alerus Investment Advisors's MD Position: Q1 2016 in Review

Alerus Investment Advisors opened a new position in Pediatrix Medical (MD) in Q1 2016: 23 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #249 among its holdings.

382 funds tracked by Wall St. Rank hold MD as of Q1 2016.

Alerus Investment Advisors held 23 shares of Pediatrix Medical worth $1K as of Q1 2016.
Pediatrix Medical was a new Alerus Investment Advisors position in Q1 2016.
Pediatrix Medical made up ﹤0.01% of Alerus Investment Advisors's portfolio in Q1 2016, its #249 holding.
382 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.